Bid Publish Date
29-Jul-2026, 8:35 am
Bid End Date
12-Aug-2026, 7:00 pm
Location
Progress
RAOrganization/not disclosed seeks procurement of pharmaceutical products across a defined drug name with dosage form and strength details. The tender references shelf life requirements and primary packaging specifications, with an emphasis on door-to-door delivery. The estimated value and EMD are not listed; however, the procurement involves product information attributes such as drug name, dosage form, strength, and packaging type. A key differentiator is the delivery model and shelf life stipulations, including a mandatory 3/4th shelf-life at delivery. The tender highlights an ATC-style terms framework and a 25% quantity variation option, signaling flexible procurement volumes within contract terms.
Drug name
Dosage Form
Strength (multiple entries)
Type of primary packing
Shelf life in months from date of manufacture
Door-to-door delivery
Delivery extended/variation up to 25%
Door-to-door delivery obligation and 3/4th shelf life at delivery
Quantity variation up to 25% with recalculated delivery period
Mandatory submission of PAN, GSTIN, cancelled cheque, and EFT mandate
Not specified in data.
Delivery must be door-to-door; extended delivery period possible for increased quantity under option clause.
Not specified in data.
PAN and GST registration
Evidence of EFT mandate and banking details
Capability to deliver medicines with 3/4th shelf life at delivery
Start
08-Sep-2026, 11:00 am
End
09-Sep-2026, 11:00 am
Duration: 24 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
Quantity
17820
Bid Type
Service
EMD Required
No
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Tender Category
Goods
Bid To RA
No
Delivery Locations
1
Delivery Cities
GHAZIABAD
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | GHAZIABAD | GHAZIABAD | - | - | - | - | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
CATALOG Specification
CATALOG Specification
CATALOG Specification
CATALOG Specification
OTHER
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS
Extended Deadline
11-Aug-2026, 4:30 am
Opening Date
11-Aug-2026, 5:00 am
PAN Card copy
GSTIN copy
Cancelled Cheque copy
EFT Mandate copy certified by Bank
| Category | Specification | Requirement |
|---|---|---|
| PRODUCT INFORMATION | Strength | 2 mg |
| SHELF LIFE | Shelf life in months from the date of manufacture | 24, 36 Or higher |
Key insights about UTTAR PRADESH tender market
Bidders must submit PAN, GSTIN, cancelled cheque, and EFT mandate; provide drug name, dosage form, strength, and primary packing type. Ensure medicines meet 3/4th shelf life at delivery and comply with delivery terms; include bank details and vendor code creation documents with bid.
Required documents include PAN, GSTIN, cancelled cheque, and EFT mandate certified by bank. Also provide technical compliance certificates if available and evidence of delivery capability for medicines with shelf-life requirements; ensure organization details match tender submission.
Medicines must have 3/4th shelf life remaining at delivery. Primary packing type must be specified in the product specification. Adhere to shelf life calculations from the date of manufacture and confirm packaging integrity upon receipt.
Delivery is door-to-door. The purchaser may increase or decrease quantity up to 25% of contract. Extended delivery period is calculated via (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days.
Verify PAN and GSTIN validity, bank EFT mandate, and capability to deliver medicines with 3/4th shelf life. Ensure ability to meet door-to-door delivery and packaging requirements; alignment with product names, dosage forms, and strengths listed in the tender.
Tender data references generic standards; explicit IS/IS 550 or ISI certifications are not clearly stated. Vendors should supply any available compliance certificates and packaging standards applicable to the specified drug name and dosage form.